Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ANVS | Annovis Bio, Inc. | Director, 10%+ Owner | $10M | Nov 20, 2023 | ||
TDAC | Translational Development Acquisition Corp. | Chief Executive Officer, Director | Dec 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|